CC Community News Digest (November 2-8)

Assorted news from the last week:

With Election Day behind us, Congress may be in a better position now to enact another round of stimulus spending — something nonprofits say they desperately need. [NOTE:  this article is gated, but access is free when you register for the site.]

Childhood Cancer in Ontario: The 2020 POGO Surveillance Report provides updated childhood cancer statistics on the impact and burden of cancer in children aged 0–14 years in Ontario.  By monitoring and publicly reporting Ontario childhood cancer statistics, POGO ensures the right data are available and being used to drive an effective childhood cancer system, one of the strategic objectives of our Childhood Cancer Care Plan: A Roadmap for Ontario 2018–2023.

Drug repurposing news:  Early information from a new study in mice and laboratory cell experiments suggests that a commonly prescribed anti-depressant (Paroxetine) may halt growth in childhood sarcoma.

Interesting discussion of the boundaries between doctors and patients:  what happens when an oncologist pays for a patient’s medicine.

Children with cancer and their caregivers don’t always report patients’ symptoms with the same degree of accuracy.  Findings suggest that health care providers should have both children and caregivers report on symptoms when possible.

Upcoming Webinars and Online Opportunities:

The inaugural Neuroblastoma Parent Global Symposium was held on November 6th and 7th, 2020.  Sessions featured information on current treatments around the world and share emerging therapies.  This information is available to view (free registration may be required).

CAC2 hosts leaders of the New Approaches to Neuroblastoma Therapy (NANT) consortium about the progress and challenges associated with developing new strategies for refractory and relapsed neuroblastoma patients. Learn about the history of this 20 year-old, multi-institution network, their collaborations with the Children’s Oncology Group and other partners, current clinical trials and plans for future studies.

View the recent webinar hosted by Children’s Cancer Cause:  “Elevating the Needs of Childhood Cancer Survivors” featuring Dr. Maria Monica Gramatges, Co-Director of the Texas Children’s Long-Term Survivor Program, and Emily S. Tonorezos, MD, MPH, newly appointed Director of the Office of Cancer Survivorship at the NCI.

View National Cancer Institute’s video series:  When a Child Has Cancer